2021胡潤中國500強:騰訊企業價值年跌1萬億仍居榜首
胡潤研究院發佈《2021胡潤中國500強》,中國500強上榜門檻提高90億元人民幣(下同)(39%),達到320億元,創歷史新高。當中,字節跳動、美團(03690.HK)及寧德時代企業價值增長最多,上升達千億美元。
騰訊(00700.HK)價值一年下跌1萬億元,但仍以3.9萬億元蟬聯中國價值最高的非國有企業;排名第二爲價值3.7萬億元的臺積電;阿裏巴巴(09988.HK)價值下跌一半至2.5萬億元,較去年排名下降一位至第三。
至於34間企業價值漲一倍以上,字節跳動價值2.3萬億元,排名上升五位至第四。
以行業分析,醫療健康和能源行業增長顯着,成爲500強企業最多的前兩大行業。而傳統醫藥和醫藥零售、房地產和教育領域跌出500強的企業最多,包括恆大(03333.HK)等。(me/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.